Preparation and evaluation of a novel buccal adhesive system

AAPS PharmSciTech

Volumn 5, Issue 3, 2004, Pages

  Desai, Kashappa Goud H ^a   Pramod Kumar, T M ^b  

^a Korea University   (South Korea)

^b JSS COLLEGE OF PHARMACY   (India)

Author keywords

Buccal delivery; Carbopol 934P; HPMC K4M; Mucoadhesion; Propranolol hydrochloride

Indexed keywords

CARBOMER; HYDROXYPROPYLMETHYLCELLULOSE; OCTANOL; PHOSPHATE; PROPRANOLOL;

ADULT; ANIMAL TISSUE; ARTICLE; CHEEK MUCOSA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; HARDNESS; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUTH CAVITY; NONHUMAN; NORMAL HUMAN; PARTITION COEFFICIENT; PH; RABBIT; SALIVA; SWINE; THICKNESS;

EID: 23144451894     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt050335     Document Type: Article

References (30)

1. Alur HH, Pather SI, Mitra AK, Johnston TP. Transmucosal sustained-delivery of chlorpheniramine maleate in rabbits using a novel natural mucoadhesive gum as an excipient in buccal tablets. Int J Pharm. 1999;188:1-10.
2. Benes L, Claustrat B, Horriere F, et al. Transmucosal, oral controlled release, and transdermal drug administration in human subjects: A cross-over study with melatonin. J Pharm Sci. 1997;86:1115-1119.
3. Alur HH, Pather SI, Mitra AK, Johnston TP. Evaluation of the gum from hakea gibbosa as a sustained release and mucoadhesive component in buccal tablets. Pharm Dev Technol. 1999;4:347-358.
4. Gavini E, Sanna V, Juliano C, Bonferoni MC, Giunchedi P. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, Acriflavine. AAPS PharmSciTech. 2002;3(3):E20.
5. Chowdary KPR, Rao YS. Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: a technical note. AAPS PharmSciTech. 2003;4(3):E39.
6. Junginger HE, Hoogstraate JA, Verhoef JC. Recent advances in buccal drug delivery and absorption: In vitro and in vivo studies. J Control Release. 1999;62:149-159.
7. Pramodkumar TM, Desai KGH, Shivakumar HG. Buccal permeation enhancers. Ind J Pharm Edu. 2002;36:147-151.
8. Nagai T, Konishi R. Buccal/gingival drug delivery systems. J Control Release. 1987;6:353-360.
9. Khanna R, Agarwal SP, Ahuja A. Preparation and evaluation of bioerodible buccal tablets containing clotrimazole. Int J Pharm. 1996;138:67-73.
10. Chen LLH, Chetty DJ, Chien YW. A mechanistic analysis to characterize oramucosal permeation properties. Int J Pharm. 1999;184:63-72.
11. Giunchedi P, Juliano C, Gavini E, Cossu M, Sorrenti M. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur J Pharm Biopharm. 2002;53:233-239.
12. Martin L, Wilson CG, Koosha F, Uchegbu IF. Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Eur J Pharm Biopharm. 2003;55:35-45.
13. Lee Y, Chien YW. Oral mucosal controlled delivery of LHRH by bilayer mucoadhesive polymer systems. J Control Release. 1995;37(3):251-261.
14. Park CR, Munday DL. Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy. Int J Pharm. 2002;237:215-226.
15. Minghetti P, Colombo A, Montanari L, Gaeta GM, Gombos F. Buccoadhesive slow-release tablets of acitretin: Design and 'in vivo' evaluation. Int J Pharm. 1998;169(2):195-202.
16. Llabot JM, Manzo RH, Allemandi DA. Double layered mucoadhesive tablets containing nystatin. AAPS PharmSciTech. 2002;3(3):E22.
17. Lopez CR, Portero A, Vila-Jato JL, Alonso MJ. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J Control Release. 1998;55:143-152.
18. Cid E, Mella F, Lucchini L, Carcamo M, Monasterio J. Plasma concentrations and bioavailability of propranolol by oral, rectal and intravenous administration in man. Biopharm Drug Dispos. 1986;7:559-566.
19. Walle T, Conradi EC, Walle UK, Fagan TC, Gaffney TE. The predictable relationship between plasma levels and dose during chronic propranolol therapy. Clin Pharmacol Ther. 1978;24:668-677.
20. Tanaka M, Yanagibashi N, Fukuda H, Nagai T. Absorption of salicylic acid through the oral mucous membrane of hamster cheek pouch. Chem Pharm Bull (Tokyo). 1980;28:1056-1061.
21. Choi HG, Kim CK. Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. J Control Release. 2000;68:397-404.
22. Mumtaz AM, Ch'ng HS. Design of a dissolution apparatus suitable for in situ release study of triamcinolone acetonide from bioadhesive buccal tablets. Int J Pharm. 1995;121(2):129-139.
23. Kerec M, Bogataj M, Mugerle B, Gasperlin M, Mrhar A. Mucoadhesion on pig vesical mucosa: Influence of polycarbophil/calcium interactions. Int J Pharm. 2002;241:135-143.
24. Spiegeleer BD, Vooren LV, Voorspoels J,Thoné D, Rosier J. Dissolution stability and IVIVC investigation of a buccal tablet. Anal Chim Acta. 2001;446:345-351.
25. Schoenwald RD, Hung HS. In vitro corneal permeation of β-blocking agents. J Pharm Sci. 1983;72:1266-1271.
26. Mahaguna V, Talbert RL, Peters JI, et al. Influence of hydroxypropyl methylcellulose polymer on in vitro and in vivo performance of controlled release tablets containing alprazolam. Eur J Pharm Biopharm. 2003;56:461-468.
27. Park H, Robinson JR. Mechanisms of mucoadhesion of poly(acrylic acid) hydrogels. Pharm Res. 1987;4:457-464.
28. Shojaei AH, Li X. Mechanisms of buccal mucoadhesion of novel copolymers of acrylic acid and polyethylene glycol monomethylether monomethacrylate. J Control Release. 1997;47(2):151-161.
29. Agarwal V, Mishra B. Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev Ind Pharm. 1999;25:701-709.
30. Capan Y, Jiang G, Giovagnoli S, Na KH, DeLuca PP. Preparation and characterization of poly (D, L-lactide-co-glycolide) microspheres for controlled release of human growth hormones. AAPS PharmSciTech. 2003;4(2):E28.